Similasan Reisekrankheit, Tabletten

7680678130013 CH-67813 Tabletten

Associated product:

SIMILASAN Maux de voyage cpr 60 pce
Similasan Reisekrankheit, Tabletten
Similasan Reisekrankheit, Tabletten
Similasan Reisekrankheit, Tabletten
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/08/2022
Patient information leaflet
Français
29/08/2022
Patient information leaflet
Italien
29/08/2022

Detailed composition

Substance Quantity Type Category
(N/A)
6.25 MG Substance Wirkstoff (Principe actif)
(N/A)
6.25 MG Substance Wirkstoff (Principe actif)
(N/A)
6.25 MG Substance Wirkstoff (Principe actif)
(N/A)
6.25 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
241.25 MG Substance HBESI

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
67813
Drug name
Similasan Reisekrankheit, Tabletten
Galenic form
TAB
Authorization status
Z
Dispensing category
D
First authorization
23/11/2021
Authorization expiration date
22/11/2026
IT Number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Reisekrankheit (Auto, Flugzeug, Schiff, Eisenbahn usw.) mit Symptomen wie Übelkeit, Erbrechen und Schwindelgefühl.

Package details

Description (FR)
SIMILASAN Maux de voyage cpr 60 pce
Description (DE)
SIMILASAN Reisekrankheit Tabl 60 Stk
Market launch
23/11/2021
Narcotic (BTM)
No